LY231514 (MTA)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LY231514 (MTA), covering 2006-07-19 to 2006-07-19. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer. [Phase 2]